Viewing Study NCT00941967


Ignite Creation Date: 2025-12-25 @ 12:44 AM
Ignite Modification Date: 2026-01-06 @ 9:20 AM
Study NCT ID: NCT00941967
Status: COMPLETED
Last Update Posted: 2019-07-10
First Post: 2009-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Liver Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult primary hepatocellular carcinoma View
None localized unresectable adult primary liver cancer View
None recurrent adult primary liver cancer View
None advanced adult primary liver cancer View